CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BofA Securities Adjusts Amgen Price Target to $328 From $317, Maintains Underperform Rating

Neutral
AI Analysis

Summary

BofA Securities adjusted Amgen's price target upward to $328 from $317 while maintaining an Underperform rating.

Importance:2/10
Sentiment:
0.00
price_targetratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on October 12, 2026 11:57 AM

Read Original